Previous close | 0.9600 |
Open | 0.9600 |
Bid | 0.3000 |
Ask | 2.7500 |
Strike | 170.00 |
Expiry date | 2025-03-21 |
Day's range | 0.9600 - 0.9600 |
Contract range | N/A |
Volume | |
Open interest | 1 |
BD's robust product portfolio and a few strategic deals raise optimism about the stock. However, stiff competition and macroeconomic volatility are concerns.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has reached an agreement to resolve the vast majority of its existing hernia litigation.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.